日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Loss of OBSCN expression promotes bladder cancer progression but enhances the efficacy of PD-L1 inhibitors.

OBSCN 表达的丧失会促进膀胱癌的进展,但会增强 PD-L1 抑制剂的疗效

Wang Tao, Guo Tuanjie, Sun Juanjuan, Zang Xinyue, Dong Lei, Zhang Jian, Chen Siteng, Chen Guihua, Ma Sicong, Zhai Xinyu, Chu Chuanmin, Wang Chaofu, Wang Xiang, Xu Dongliang, Tan Mingyue

Deep learning-based multi-model prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort study

基于深度学习的多模型预测透明细胞肾细胞癌患者术后无病生存状态:一项多中心队列研究

Chen, Siteng; Gao, Feng; Guo, Tuanjie; Jiang, Liren; Zhang, Ning; Wang, Xiang; Zheng, Junhua

Deep learning-based pathological prediction of lymph node metastasis for patient with renal cell carcinoma from primary whole slide images

基于深度学习的肾细胞癌患者淋巴结转移病理预测:基于原发性全切片图像

Gao, Feng; Jiang, Liren; Guo, Tuanjie; Lin, Jun; Xu, Weiqing; Yuan, Lin; Han, Yaqin; Yang, Jiji; Pan, Qi; Chen, Enhui; Zhang, Ning; Chen, Siteng; Wang, Xiang

Artificial intelligence-based non-invasive tumor segmentation, grade stratification and prognosis prediction for clear-cell renal-cell carcinoma

基于人工智能的非侵入性肿瘤分割、分级分层和预后预测在透明细胞肾细胞癌中的应用

Chen, Siteng; Song, Dandan; Chen, Lei; Guo, Tuanjie; Jiang, Beibei; Liu, Aie; Pan, Xianpan; Wang, Tao; Tang, Heting; Chen, Guihua; Xue, Zhong; Wang, Xiang; Zhang, Ning; Zheng, Junhua

Integrative analysis of ferroptosis regulators for clinical prognosis based on deep learning and potential chemotherapy sensitivity of prostate cancer

基于深度学习的铁死亡调节因子整合分析及其在前列腺癌临床预后和潜在化疗敏感性中的作用

Guo, Tuanjie; Yuan, Zhihao; Wang, Tao; Zhang, Jian; Tang, Heting; Zhang, Ning; Wang, Xiang; Chen, Siteng

Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancer.

p53 和 YY1 之间的竞争决定了膀胱癌中 PHGDH 的表达和恶性程度。

Shi Tiezhu, Yuan Zhihao, He Yanying, Zhang Dongliang, Chen Siteng, Wang Xiongjun, Yao Linli, Shao Jialiang, Wang Xiang

Development and verification of a deep learning-based m(6)A modification model for clinical prognosis prediction of renal cell carcinoma.

开发和验证基于深度学习的m(6)A修饰模型用于肾细胞癌的临床预后预测

Chen Siteng, Zhang Encheng, Guo Tuanjie, Wang Tao, Chen Jinyuan, Zhang Ning, Wang Xiang, Zheng Junhua

Genome-Wide 3'-UTR Single Nucleotide Polymorphism Association Study Identifies Significant Prostate Cancer Risk-Associated Functional Loci at 8p21.2 in Chinese Population

全基因组3'-UTR单核苷酸多态性关联研究发现中国人群8p21.2位点存在与前列腺癌风险显著相关的功能位点

Zhang, Ning; Huang, Da; Jiang, Guangliang; Chen, Siteng; Ruan, Xiaohao; Chen, Haitao; Huang, Jingyi; Liu, Ao; Zhang, Wenhui; Lin, Xiaoling; Wu, Yishuo; Zhang, Qin; Li, Jing; Tsu, James Hok-Leung; Wei, Gong-Hong; Na, Rong

CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma.

CDK1/FBXW7 促进 MLST8 的降解和泛素化,从而抑制肾细胞癌的进展

Zhang Encheng, Chen Siteng, Tang Heting, Fei Cheng, Yuan Zhihao, Mu Xingyu, Qin Yan, Liu Haixia, Fan Yu, Tan Mingyue, Wang Xiang

HIF1A predicts the efficacy of anti-PD-1 therapy in advanced clear cell renal cell carcinoma

HIF1A 可预测抗 PD-1 疗法在晚期透明细胞肾细胞癌中的疗效

Guo, Tuanjie; Wang, Tao; Zhang, Jian; Chen, Siteng; Wang, Xiang